B2DB — Who said what, where, and when

Anne Michel

CEO, HERMIONE THERAPEUTICS

Hermione Therapeutics develops a game changer platform enabling bacterial biofilm dispersion. ANP is our 1st lead as smart companion enhancing SoC antibiotics and preventing dose escalation in chronic respiratory diseases.

Events Anne Michel has spoken at